Status:
COMPLETED
Clinical Assessment of Chitosan Nanoparticles on Periodontal Problems Post Steroidal Inhalation in Asthmatic Patients: Phase I Trial
Lead Sponsor:
Deraya University
Conditions:
Periodontal Diseases
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
Periodontal problems management is the most important goals of chronic asthmatic patients that adapted to use steroid inhalation for long time. Gram negative anaerobic bacteria are generally suggested...
Eligibility Criteria
Inclusion
- Age from 18-50 years old
- Both sex male and female
- Patients diagnosed as Asthmatic
- Patients treated with corticosteroids inhaler or ( beta2-adrenergic agonist inhaler or nebulizer for their symptoms)
Exclusion
- Patients treated with other medication
- Patients not diagnosed as asthmatic
- Comorbidity
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06525363
Start Date
August 1 2024
End Date
March 1 2025
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soad A. Mohamad
Minya, Select Region, Egypt, 05673